Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer

Qianping Li, Weijie Ma, Tianhong Li

Research output: Contribution to journal › Review article

Cite this

@article{fbc564e6a241448d9a30c1021c944d14,

title = "Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer",

author = "Qianping Li and Weijie Ma and Tianhong Li",

year = "2018",

month = sep,

day = "1",

doi = "10.21037/jtd.2018.08.25",

language = "English (US)",

volume = "10",

pages = "S3186--S3191",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",

publisher = "Pioneer Bioscience Publishing Company (PBPC)",

}

TY - JOUR

T1 - Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer

AU - Li, Qianping

AU - Ma, Weijie

AU - Li, Tianhong

PY - 2018/9/1

Y1 - 2018/9/1

UR - http://www.scopus.com/inward/record.url?scp=85053798582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053798582&partnerID=8YFLogxK

U2 - 10.21037/jtd.2018.08.25

DO - 10.21037/jtd.2018.08.25

M3 - Review article

AN - SCOPUS:85053798582

VL - 10

SP - S3186-S3191

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

ER -